Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15885
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bio-Rad Laboratories Inc (BIO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories, and physician office laboratories. The company offers its products through direct sales force and also through a network of distributors, agents, brokers and resellers across the world. The company operates in the US, Canada, Latin America, Europe and Pacific Rim, among others. Bio-Rad is headquartered in Hercules, California, the US.

Bio-Rad Laboratories Inc Key Recent Developments

Apr 02,2019 Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
Feb 28,2019 Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
Feb 14,2019 2/15/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Feb 14,2019 2/21/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response: Bio-Rad Laboratories Inc.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bio-Rad Laboratories Inc – Key Facts
Bio-Rad Laboratories Inc – Key Employees
Bio-Rad Laboratories Inc – Key Employee Biographies
Bio-Rad Laboratories Inc – Major Products and Services
Bio-Rad Laboratories Inc – History
Bio-Rad Laboratories Inc – Company Statement
Bio-Rad Laboratories Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Bio-Rad Laboratories Inc – Business Description
Business Segment: Clinical Diagnostics
Overview
Performance
Key Stats
Business Segment: Life Science
Overview
Performance
Key Stats
Geographical Segment: Europe
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: Pacific Rim
Performance
Geographical Segment: United States
Performance
Bio-Rad Laboratories Inc – Corporate Strategy
Bio-Rad Laboratories Inc – SWOT Analysis
SWOT Analysis – Overview
Bio-Rad Laboratories Inc – Strengths
Bio-Rad Laboratories Inc – Weaknesses
Bio-Rad Laboratories Inc – Opportunities
Bio-Rad Laboratories Inc – Threats
Bio-Rad Laboratories Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
Feb 14, 2019: 2/15/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Feb 14, 2019: 2/21/19 – Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response: Bio-Rad Laboratories Inc.
Feb 01, 2019: Bio-Rad showcases new automation features of its ZE5 cell analyzer at SLAS 2019
Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories
Dec 03, 2018: Research highlights ability of Bio-Rad’s ddPCR in quantifying minimal residual disease
Dec 03, 2018: Bio-Rad quality controls now available for multiple Abbott clinical diagnostics platforms
Nov 14, 2018: Bio-Rad and the University of Chicago win patent infringement case against 10X Genomics related to droplet microfluidics technologies
Nov 01, 2018: Bio-Rad reports third-quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bio-Rad Laboratories Inc, Key Facts
Bio-Rad Laboratories Inc, Key Employees
Bio-Rad Laboratories Inc, Key Employee Biographies
Bio-Rad Laboratories Inc, Major Products and Services
Bio-Rad Laboratories Inc, History
Bio-Rad Laboratories Inc, Subsidiaries
Bio-Rad Laboratories Inc, Key Competitors
Bio-Rad Laboratories Inc, Ratios based on current share price
Bio-Rad Laboratories Inc, Annual Ratios
Bio-Rad Laboratories Inc, Annual Ratios (Cont...1)
Bio-Rad Laboratories Inc, Annual Ratios (Cont...2)
Bio-Rad Laboratories Inc, Interim Ratios
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bio-Rad Laboratories Inc, Performance Chart (2014 - 2018)
Bio-Rad Laboratories Inc, Ratio Charts
Bio-Rad Laboratories Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Bio-Rad Laboratories Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RadiSys Corporation (RSYS):企業概要、財務及び戦略的SWOT分析
    Summary RadiSys Corporation (RadiSys) is an information technology solution provider. The company provides embedded wireless infrastructure solutions for telecom, aerospace, defense, and public safety applications. Its product portfolio includes ATCA, trillium, media server, security gateway, COM ex …
  • PKN Orlen S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PKN Orlen S.A. Mergers and Acqu …
  • Biosense Webster, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Biosense Webster, Inc. (Biosense Webster) is a medical device company. The company designs, manufactures and distributes products for diagnosis and treatment of cardiac arrhythmias. Its products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Electro Scientific Industries, Inc. (ESIO):企業財務及び戦略的SWOT分析
    Summary Electro Scientific Industries, Inc. (ESI) is a technology company that offers electronic equipment. The company provides laser-based manufacturing solutions, and engineering and testing of micron to submicron features in semiconductors, LEDs, multi-layer ceramic capacitors, printed circuit b …
  • Diamondback Energy, Inc. (FANG):企業財務及び戦略的SWOT分析
    Summary Diamondback Energy, Inc. (Diamondback Energy) is an oil and gas company that offers exploration and development programs. The company acquires, develops, explores and exploits unconventional, long-life, onshore oil and natural gas reserves in Permian Basin in West Texas. It develops the rese …
  • Topcon Corporation (7732):企業概要、財務及び戦略的SWOT分析
    Summary Topcon Corporation (Topcon) is a medical device manufacturing company. The company’s products include positioning and smart infrastructure and eye care. Its positioning and smart infrastructure products include TOCON brand and SOKKIA brand. Topcon’s TOCON and SOKKIA brand products include GN …
  • Symplmed Inc:企業のM&A・提携動向(医療分野)
    Summary Symplmed Inc (Symplmed) is a pharmaceutical company that focuses on streamlining the prescription process for boosting value of its medicines and those of its industry partners. The company offers patented technology platform, DyrctAxess to enables direct delivery of medications to patient’s …
  • Tris Pharma, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tris Pharma, Inc. Mergers and A …
  • Watson Pharma, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Watson Pharma, Inc. Mergers and …
  • ASSA ABLOY AB:企業のM&A・提携・投資分析
    ASSA ABLOY AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ASSA ABLOY AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • American Oriental Bioengineering, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Oriental Bioengineerin …
  • Ascendance Biotechnology Inc-医療機器分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • State Oil Company of the Azerbaijan Republic:石油・ガス:M&Aディール及び事業提携情報
    Summary State Oil Company of the Azerbaijan Republic (SOCAR) is an oil and gas exploration company. The company explores oil and gas fields; and produces, processes and transports oil, gas and gas condensate. It markets petroleum and petrochemical products in domestic and international markets and s …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • National Cancer Institute:企業のM&A・提携動向(医療分野)
    Summary National Cancer Institute (NCI), a subsidiary of National Institutes of Health, is a provider of cancer research and training services. NCI coordinates National Cancer Program (NCP) that supports and coordinates research projects that universities, hospitals, research foundations and busines …
  • Petroleos de Venezuela S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Petroleos de Venezuela S.A. Mer …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Zimmer Biomet Holdings Inc.:企業の戦略・SWOT・財務分析
    SummaryZimmer Biomet Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • Compal Electronics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Compal Electronics, Inc. Merger …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆